SANOFI-AVENTIS has entered
into an agreement with Oramed
Pharmaceuticals which will see it
supply Oramed with recombinant
human insulin which will be used
in Oramed’s US clinical trials.
“Oramed’s oral delivery
technology together with sanofiaventis’
capabilities to produce
insulin on a large scale supports
Oramed’s efforts to conduct
clinical development of Oramed’s
oral insulin capsule in the growing
diabetes market in the US,” said
Nadav Kidron, Oramed’s ceo.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Jul 10
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.